GlobeNewswire by notified

Calibre Scientific Acquires Glass Chemicals, a Comprehensive Provider of Laboratory Consumables, Equipment and Services in Spain

Share

LOS ANGELES, Jan. 16, 2023 (GLOBE NEWSWIRE) -- Calibre Scientific is pleased to announce the acquisition of Glass Chemicals (the “Company”), a Spanish distributor of scientific consumables, equipment and services for the life sciences, diagnostics, and industrial sectors. Glass Chemicals is Calibre Scientific’s second acquisition in Spain, and further expands its presence across the entire Spanish market including offices and warehouses in the key regions of Madrid and Barcelona.

Glass Chemicals markets and distributes products for laboratory, hospital and pharmaceutical customers. Its capabilities also include after-sales service, packaging, sterilization management as well as medical and non-medical product customization performed in a cleanroom setting.

With this acquisition, Calibre Scientific gains another strategic partner in the laboratory supplies market and adds additional focus on providing key services to the industry. “Glass Chemicals is a trusted brand in Spain with strong customer relationships and an impressive offering of products and services,” said Ben Travis, Chief Executive Officer of Calibre Scientific. “We are excited to collaborate with the management team and leverage their unique market knowledge and customer relationships which together with Calibre Scientific’s existing distributor, Serviquimia, will further strengthen our ability to service a broad customer base across all of Spain.”

“The Calibre Scientific team was great to work with, delivered at each step of this process and I am very enthusiastic about our new partnership together,” said Alejandro del Álamo Gutiérrez, Chief Executive Officer of Glass Chemicals. “At Glass Chemicals, we have always prioritized the success of our customers and taken pride in our ability to adapt to their needs as both a distributor and provider of vital services. With shared values and strong strategic expertise, I am excited to see Calibre Scientific take us to the next level.”

About Calibre Scientific

Calibre Scientific is a diversified global provider of life science reagents, tools, instruments, and other consumables to the lab research, diagnostics, industrial, and biopharmaceutical communities. Calibre Scientific owns a portfolio of life science and diagnostic companies that have an unrivaled ability to address its customers’ challenges in their respective markets. Our global reach extends to over 175 countries, empowering customers all over the world. Headquartered in Los Angeles, California, Calibre Scientific continues to expand its product offering and global footprint to laboratories across a wide array of verticals and geographies. 

For more information, visit www.investor.calibrescientific.com, or contact press@calibrescientific.com.

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Standard Lithium and Equinor Form Partnership to Develop South West Arkansas and East Texas Lithium Projects8.5.2024 14:00:00 CEST | Press release

Equinor Commits to Contribute up to a US$160 million Gross Investment for a 45% interest in two special purpose entities with SLI to develop a sustainable lithium business in the United States VANCOUVER, British Columbia, May 08, 2024 (GLOBE NEWSWIRE) -- Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV:SLI) (NYSE American:SLI) (FRA:S5L), a leading near-commercial lithium development company, today announced the closing of a landmark strategic partnership (the “Transaction”) with Equinor ASA (NYSE: EQNR), a multinational energy company and recognized leader in renewables and low-carbon solutions, to accelerate the development of Standard Lithium’s large-scale, sustainable lithium projects in the Smackover Formation. The Transaction includes Equinor's contribution of up to US$160 million, representing its total gross project-level investment and reflecting its 45% ownership stake in the two entities. This investment includes a US$30 million cash payment to Standard Lithi

Atlantica Reports First Quarter 2024 Financial Results8.5.2024 13:23:11 CEST | Press release

Revenue for the first quarter of 2024 remained stable at $242.9 million, compared with $242.5 million in the first quarter of 2023.Adjusted EBITDA was $164.2 million, a 0.9%1 year-over-year decrease on a comparable basis.Net loss for the first quarter of 2024 attributable to the Company was $5.4 million, compared with a net loss of $11.0 million in the first quarter of 2023.Operating Cash Flow increase of 57.3% year-over-year up to $65.6 million. Signed a 15-year PPA for a 100 MW solar + storage project in California.Closed the acquisition of two wind assets in operation in the UK at 6.6x EV2 / EBITDA3 multiple.Quarterly dividend of $0.445 per share approved by the Board of Directors.Strategic Review ongoing. May 8, 2024 – Atlantica Sustainable Infrastructure plc (NASDAQ: AY) (“Atlantica” or the “Company”) today reported its financial results for the first quarter of 2024. Revenue for the first quarter of 2024 was $242.9 million, a 0.2% increase compared with the first quarter of 2023.

Wolters Kluwer 2024 Annual General Meeting of Shareholders adopts all resolutions8.5.2024 13:08:18 CEST | Press release

PRESS RELEASE Wolters Kluwer 2024 Annual General Meeting of Shareholders adopts all resolutions Shareholders approve a total dividend of €2.08 per ordinary share Alphen aan den Rijn – May 8, 2024 – Wolters Kluwer (Euronext: WKL), a global leader of professional information, software solutions, and services, announces that all resolutions were adopted as proposed at today’s Annual General Meeting of Shareholders (AGM). Composition Supervisory Board David Sides has been appointed as a member of the Supervisory Board of Wolters Kluwer for a term of four years. Mr. Sides is President and CEO of NextGen Healthcare, a leading provider of innovative technology solutions focused on ambulatory care. Sophie Vandebroek has been reappointed as a member of the Supervisory Board for a second term of four years, and Jack de Kreij has been reappointed for a two-year term. Jeanette Horan, whose second four-year term expired after the AGM, regretfully has informed Wolters Kluwer that she is not availabl

Brookfield Asset Management Announces Strong First Quarter Results8.5.2024 12:45:00 CEST | Press release

Insurance Flows and Castlelake Add $75 Billion of AUM Since Quarter End $106 Billion of Dry Powder Available to Invest BROOKFIELD, NEWS, May 08, 2024 (GLOBE NEWSWIRE) -- Brookfield Asset Management Ltd. (NYSE: BAM, TSX: BAM) today announced financial results for the quarter ended March 31, 2024. Connor Teskey, President of Brookfield Asset Management stated, “We are off to a strong start in 2024 and are seeing accelerating momentum across our business as transaction activity picks up. We raised $20 billion of capital during the first quarter ($10 billion since our last earnings release), and with more than $100 billion of dry powder to invest, both the diversity of our business mix and our global footprint mean that we remain very well-positioned to capture investment opportunities.” He continued, “We recently completed a $50 billion asset management mandate with American Equity Investment Life (AEL) and announced our intention to acquire a majority stake in Castlelake, a leader in ass

Compass Pathways Announces First Quarter 2024 Financial Results and Business Highlights8.5.2024 12:45:00 CEST | Press release

COMP360 phase 3 pivotal program in treatment-resistant depression (TRD) on track for top-line COMP005 trial data in fourth quarter 2024, COMP006 trial top-line data expected mid-2025Compass announces positive phase 2 COMP360 data in post-traumatic stress disorder (PTSD)Michael Gold to join Compass as Head of R&DCompass enters into additional commercial collaborations, including with Reliant Medical Group, part of Optum Care Cash position of $262.9 million at March 31, 2024 Conference call May 8 at 8:00 am ET (1:00 pm UK) LONDON, May 08, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today reported its financial results for the first quarter 2024 and provided an update on recent business progress. Kabir Nath, Chief Executive Officer, said, “We were pleased to see the positive results from the phase 2 PTSD study, a condition with significant unmet nee

HiddenA line styled icon from Orion Icon Library.Eye